New genetic test for X-linked dystonia-parkinsonism (XDP) developed.
Test targets specific DNA changes in the TAF1 gene.
XDP mainly affects men of Filipino ancestry.
Symptoms include muscle spasms, tremors, and impaired movement.
Traditional methods miss specific genetic changes; new test improves diagnosis.
Management focuses on symptomatic treatments like therapy and medication.
Increased testing awareness could help at-risk populations.
No current cure for XDP is available.
New Genetic Test Targets Rare X-Linked Movement Disorder
A targeted assay, presented at AMP 2025, identifies disease-specific TAF1 variants that standard panels often miss.
12/03/2025
News
3 min read
